Therabron Therapeutics

BiotechnologySeries BRockville, UStherabron.com

Latest round

Series B

Last raised

Nov 2015

Total raised

$6.8M

Investors

1

About Therabron Therapeutics

Therabron Therapeutics, founded in 2007 and headquartered in Rockville, US, develops therapeutics for respiratory diseases.75 mn.The company specializes in developing innovative biopharmaceutical products aimed at treating severe respiratory conditions.The company's revenue model is based on multiple streams, primarily including sales from its therapeutics.Therabron Therapeutics is planning to expand its product offerings by launching new therapeutics designed to address unmet needs in respiratory medicine. The company is focused on entering new markets across North America and Europe by the end of 2023.

Who invested in Therabron Therapeutics

1 investor across 1 round

See all investors in Therabron Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 9, 2015

    Amount

    $6.8M

    Investors

    Locked

Questions about Therabron Therapeutics

Who invested in Therabron Therapeutics?

Therabron Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Therabron Therapeutics raised?

Therabron Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Therabron Therapeutics last raise money?

Therabron Therapeutics's most recent round on record is a Series B, in Nov 2015.

What does Therabron Therapeutics do?

Therabron Therapeutics, founded in 2007 and headquartered in Rockville, US, develops therapeutics for respiratory diseases.

Where is Therabron Therapeutics headquartered?

Therabron Therapeutics is headquartered in Rockville, US.

Which VCs invest in companies like Therabron Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Therabron Therapeutics's stage. Their profiles are linked below.

Raising like Therabron Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.